Chicago Trust’s Ardelyx ARDX Stock Holding History

Chicago Trust’s Portfolio ARDX Stock Details ARDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,200	Closed	-$77K	–	386
2025 Q4	$77K	Hold	13,200	–	–	0.01%	380
2025 Q3	$72.7K	Buy	+13,200	New	+$71.7K	0.01%	408

Other funds holding ARDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Chicago Trust's ARDX Position: Q1 2026 in Review

Chicago Trust sold out of Ardelyx (ARDX) in Q1 2026, closing a stake of 13,200 shares — an estimated $77K sold.

Chicago Trust first reported a position in ARDX in Q3 2025 and held it in 2 quarters. The position peaked at $77K in Q4 2025. 242 funds tracked by Wall St. Rank hold ARDX as of Q1 2026.

Chicago Trust reported no remaining Ardelyx position as of Q1 2026 after selling out during the quarter.
Chicago Trust sold 13,200 Ardelyx shares in Q1 2026, an estimated $77K.
Chicago Trust first reported a position in Ardelyx in Q3 2025 and held it in 2 quarters.
Chicago Trust's Ardelyx position peaked at $77K in Q4 2025.
242 funds tracked by Wall St. Rank held Ardelyx as of Q1 2026.

Based on Chicago Trust's 13F filing for Q1 2026, filed 24 Apr 2026.